OMIC Investors Have the Opportunity to Join Investigation of Singular Genomics Systems, Inc. with the Schall Law Firm

Posted on by

LOS ANGELES, Jan. 28, 2025 /PRNewswire/ — The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in Singular Genomics Systems, Inc. (“Singular Genomics” or “the Company”) (NASDAQ: OMIC) for potential breaches…